Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2003
03/26/2003CN1406228A 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
03/26/2003CN1406226A Novel malonic acid derivatives, process for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
03/26/2003CN1406223A Protease inhibitor and their pharmaceutical uses
03/26/2003CN1406135A In ovo protection against infections bronchitis
03/26/2003CN1406124A Nasally administrable cyclic peptide compositions
03/26/2003CN1406111A Nutritional formulation containing prebiotic substances
03/26/2003CN1405177A Rabdosia lophanthide extractive, natural medicine for treating hepatitis
03/26/2003CN1405164A Corter pseudolaricis acid derivatives, preparation method and use thereof
03/26/2003CN1405157A Novel diazo alcoholic antifungal compound and its salt
03/26/2003CN1404875A B-type hepatitis vaccine
03/26/2003CN1404874A Method for preparing thermal purifying-inactivating vaccine to bleeding of double-adicity vero cell kidney syndrome and use thereof
03/26/2003CN1404873A Typhoid vaccine
03/26/2003CN1404868A Chinese medicinal preparation for treating pyretic stranguria
03/26/2003CN1404865A Preparatory Chinese medicine for treating liver disease
03/26/2003CN1404861A Compound medicine for treating AIDS
03/26/2003CN1404842A Chemical for preventing mycosis of silkworm and its preparation method thereof
03/26/2003CN1404840A Anti-HIV medicine zidovudine powder injection and its preparation method thereof
03/26/2003CN1404834A Antibiotics composition with synergistic effect to generation of beta lactamase medicine-resisting strain
03/26/2003CN1404833A 药物组合物 The pharmaceutical composition of
03/26/2003CN1404825A Novel decanoy acetaldelzy sodium intravenous preparation and its preparing method thereof
03/26/2003CN1103781C Abundant extracellular product and methods for production and use of same
03/26/2003CN1103603C Inactivated respiratory syncytial viral vaccines
03/26/2003CN1103593C Synergistic composition
03/26/2003CN1103544C Improved method for systemic administration of 2,4-dienoic acid-type insecticides to terrestrial mammals
03/26/2003CA2423858A1 Novel proteins, genes encoding them and method of using the same
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003US6538149 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
03/25/2003US6538123 Vaccine composition for preventing or treating hepatitis C
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538116 For therapy of inflammatory or painful disorder
03/25/2003US6538114 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
03/25/2003US6538106 Compositions and methods for treating infections using analogues of indolicidin
03/25/2003US6538021 Method for producing luteolin and luteolin derivatives
03/25/2003US6538015 Anti-HIV pyrazole derivatives
03/25/2003US6538009 Pyrazole derivatives as anti-inflammatory/analgesic agents
03/25/2003US6537993 Compounds for enhancing chemotherapy
03/25/2003US6537989 A process for preparing compounds of the formula I as claimed in claim 3, wherein the nucleophilically replaceable group L is halide, C1-C4-alkylsulfonate, C1-C12-alkylphenylsulfonate or mono C1-C4-alkyl sulfate.
03/25/2003US6537975 Aryl phosphate derivatives of d4T with para-bromo substitution on the aryl group show markedly increased potency as anti-HIV agents without undesirable levels of cytotoxic activity. In particular, these derivatives are potent
03/25/2003US6537972 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
03/25/2003US6537812 Methods for the production of TcRγδ+ T cells
03/25/2003US6537809 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
03/25/2003US6537804 Expression vector comprising a DNA sequence that expresses a peptide of given amino acid sequence which includes tyrosine; use in diagnosis and treatment of leukemia
03/25/2003US6537784 Self-regulated apoptosis of inflammatory cells by gene therapy
03/25/2003US6537774 UPS (undecaprenyl diphosphate synthase
03/25/2003US6537591 Aquatic animal treatment method and composition containing Pimenta extract
03/25/2003US6537583 Method for preparing capsules consisting of a liquid active material core enclosed in a mineral coating
03/25/2003US6537570 Method of biological control
03/25/2003US6537559 Staphylococcus aureus antigen-containing whole cell vaccine
03/25/2003US6537557 Strain 341750 PDK-6
03/25/2003US6537556 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation process
03/25/2003US6537555 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
03/25/2003US6537546 Process for macromolecularizing phenolic compounds etc. and use thereof
03/25/2003US6537538 Polystyrene sulfonate inhibits Trichomonas, Gardnerella, and other vaginitis/vaginosis-causing bacteria
03/25/2003US6537265 Method for nasal application of a medicinal substance
03/25/2003CA2423800A1 Fused cyclic compounds and medicinal use thereof
03/25/2003CA2234319C Fluoro-substituted adamantane derivatives
03/25/2003CA2088370C New use of monoclonal antibody
03/25/2003CA2051239C Prodrugs of phosphonates
03/20/2003WO2003023054A1 New assay for inhibitors of translocases
03/20/2003WO2003023042A1 Recombinant mva capable of expressing structural hcv antigens
03/20/2003WO2003023041A2 Infectious and attenuated bovine viral diarrhea virus clone; methods for their production and use
03/20/2003WO2003023028A1 Fungal glyoxal oxidases
03/20/2003WO2003023026A1 Alphavirus replicon vector systems
03/20/2003WO2003023025A1 Multiplication of viruses in a cell culture
03/20/2003WO2003023021A2 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
03/20/2003WO2003023015A2 Method for expression of small antiviral rna molecules within a cell
03/20/2003WO2003023014A2 Human ion channels
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003023001A2 Novel proteins and nucleic acids encoding same
03/20/2003WO2003022886A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
03/20/2003WO2003022883A2 Use of proteins for the production of a medicament for stimulating the innate non specific immune system
03/20/2003WO2003022880A2 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003WO2003022879A2 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
03/20/2003WO2003022869A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof
03/20/2003WO2003022853A1 Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol
03/20/2003WO2003022845A1 Pyrazolo-pyridines for the treatment of herpes infections
03/20/2003WO2003022842A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003WO2003022830A1 Benzothiepine ileal bile acid transport inhibitors
03/20/2003WO2003022824A1 Oxazolidinone and/or isoxazoline as antibacterial agents
03/20/2003WO2003022814A1 Indole derivatives
03/20/2003WO2003022813A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022787A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions
03/20/2003WO2003022360A2 Thermotherapy via targeted delivery of nanoscale magnetic particles
03/20/2003WO2003022324A1 Medical devices containing rapamycin analogs
03/20/2003WO2003022298A2 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003WO2003022294A2 Extract obtainable from artemisia abrotanum l. (southernwood)
03/20/2003WO2003022289A1 Erythromycin derivative-containing medicine for treatment for or prevention of tuberculosis
03/20/2003WO2003022286A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2003022273A1 Methods of treating cytokine mediated diseases
03/20/2003WO2003022267A1 Pharmaceutical compositions containing terbinafin and use thereof
03/20/2003WO2003022266A1 Hypoestoxides, derivatives and agonists thereof for use as inhibitors of angiongenesis
03/20/2003WO2003022253A1 Dosage forms having prolonged active ingredient release
03/20/2003WO2003022252A2 Combinatorial type (several vehicles within a housing) controlled release drug delivery device
03/20/2003WO2003022246A1 Treating effects of excessive reactive oxygen species
03/20/2003WO2003022242A1 Preparation of sustained release pharmaceutical composition
03/20/2003WO2003022225A2 Compositions comprising mixtures of therapeutic proteins and methods of producing the same
03/20/2003WO2003022218A2 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
03/20/2003WO2003022217A2 Treatment of excessive radiation (e.g. sunburn) exposure
1 ... 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 ... 1798